• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Viking Thera (NQ: VKTX )

    79.58 +4.16 (+5.52%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Apr 30, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 3,794,647
    Open 75.00
    Bid (Size) 78.14 (2)
    Ask (Size) 78.65 (1)
    Prev. Close 75.42
    Today's Range 74.80 - 80.25
    52wk Range 8.280 - 99.41
    Shares Outstanding 99,581,693
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    10 Health Care Stocks With Whale Alerts In Today's Session
    Via Benzinga
    Check Out What Whales Are Doing With VKTX
    Via Benzinga

    Performance

    YTD
    +335.34%
    +335.34%
    1 Month
    +0.10%
    +0.10%
    3 Month
    +234.09%
    +234.09%
    6 Month
    +711.21%
    +711.21%
    1 Year
    +259.76%
    +259.76%

    More News

    Read More
    Is Viking Therapeutics Incredibly Undervalued?
    Via The Motley Fool
    Can This High-Flying Stock 10x in 10 Years?
    Via The Motley Fool
    1 Little-Known Vanguard Index Fund to Buy Before It Soars 50%, According to a Wall Street Analyst
    Via The Motley Fool
    Viking Therapeutics Unusual Options Activity
    Via Benzinga
    Looking At Viking Therapeutics's Recent Unusual Options Activity
    Via Benzinga
    Market Whales and Their Recent Bets on VKTX Options
    Via Benzinga
    3 Biotech Stocks to Buy on the Dip: April 2024
    Via InvestorPlace
    3 Millionaire-Maker Biotech Stocks
    Via The Motley Fool
    VKTX Stock Earnings: Viking Therapeutics Beats EPS for Q1 2024
    Via InvestorPlace
    Viking Therapeutics Reports Q1 Results: 'An Exceptional Period' Says CEO
    Via Benzinga
    3 Biotech Stocks With Skyrocketing Potential: April 2024
    Via InvestorPlace
    3 Red-Hot Biotech Rockets Blasting Off in 2024
    Via InvestorPlace
    Topics Economy
    Exposures Economy
    $100 Invested In Viking Therapeutics 5 Years Ago Would Be Worth This Much Today
    Via Benzinga
    Missed Out on Novo Nordisk? 2 Healthcare Stocks With Big Catalysts on the Horizon.
    Via The Motley Fool
    Better Buy: Pfizer vs. Viking Therapeutics
    Via The Motley Fool
    1 No-Brainer Vanguard Fund to Buy Right Now
    Via The Motley Fool
    3 Stocks With the Potential to Surpass Analyst Expectations for 2024
    Via InvestorPlace
    Wegovy vs. Zepbound: Who Wins the Battle of the GLP-1 Drugs?
    Via MarketBeat
    These 3 Biotech Stocks Are Up 269% in 2024. Is There More to Come?
    Via InvestorPlace
    Viking Therapeutics: Strong Results In Obesity
    Via Talk Markets
    3 Magnificent Stocks That Could Double or More by 2030
    Via The Motley Fool
    Shed the Fat, Gain the Profits: 3 Weight-Loss Stocks to Own Until 2027
    Via InvestorPlace
    If You Can Only Buy One Biotech Stock in April, It Better Be One of These 3 Names
    Via InvestorPlace
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.